![]() |
市場調查報告書
商品編碼
2037387
腦健康營養市場:未來預測(至2034年)-按成分類型、劑型、年齡層、標籤、通路、應用、最終用戶和地區分類的全球分析Brain Health Nutrition Market Forecasts to 2034 - Global Analysis By Ingredient Type (Omega-3 Fatty Acids, Nootropics, Vitamins & Minerals and Amino Acids), Form, Age Group, Claim Type, Distribution Channel, Application, End User and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球腦健康營養市場將達到 184 億美元,並在預測期內以 12.9% 的複合年成長率成長,到 2034 年達到 486 億美元。
腦健康營養是指含有Omega-3脂肪酸、促智成分、維生素、礦物質和胺基酸的營養補充品和營養補充產品,旨在支持記憶力、注意力、處理速度等認知功能,並預防與老齡化相關的認知衰退。這些產品以膳食補充劑、功能性飲料、功能性食品和嬰幼兒營養食品的形式提供,旨在透過循證營養干預策略,支持老齡化、處理速度等認知功能,預防與年齡相關的認知衰退,促進嬰幼兒時期的大腦發育,並透過涵蓋從產前發育到兒童整個生命週期的營養干預策略,維持思維機能飲料和情緒機能性食品。
消費者對最佳化認知功能的投資
在提高職業效率、維持健康老齡化中的認知功能以及促進兒童發育等因素的驅動下,消費者對認知最佳化方面的投入不斷增加,由此催生了一個龐大而多元化的腦健康營養市場,其應用涵蓋了從嬰兒期補充DHA到老年人預防失智症各個生命階段。人們對生活方式和營養因素在長期認知健康結果中的作用日益關注,加之主流健康媒體對神經科學研究成果的廣泛報道,正在培養一個涵蓋各個年齡段和不同功能目標群體的、知識淵博的消費者群體,他們正積極投資於基於實證的腦健康營養干預措施。
與腦健康相關的標籤監管限制
根據美國食品藥物管理局 (FDA) 和歐洲食品安全局 (EFSA) 的規定,食品和膳食補充劑產品中關於大腦健康和認知功能益處的聲明受到嚴格的監管限制。允許的關於認知、記憶和精神功能的聲明僅限於定義廣泛的結構性和功能性聲明。這限制了針對大腦健康營養品牌的消費者教育的有效性,因此需要投入大量資金用於教育內容行銷,以傳達成分作用機制背後的科學證據,同時避免觸發可能導致其無法用於疾病治療或認知增強藥物標籤的監管分類。
老年人認知健康預防市場
全球人口老化加劇,越來越多的老年消費者積極尋求營養策略以維持認知功能並降低失智症的風險,這為腦健康營養市場帶來了巨大的機會。在此背景下,醫療保健專業人員的參與、看護者對購買決策的影響,以及消費者群體對認知保護的高度重視,都為高級產品的定價提供了合理的依據。已有的臨床證據表明, Omega-3、B群維生素和絲胺酸能夠有效支持老年人的認知功能,這為高階腦健康營養產品提供了強力的專家推薦管道。
認知功能改善藥物的研發管線競爭
已通過核准的認知增強和失智症預防療法產品線正在不斷擴展,並吸引大量臨床試驗投資。如果這些療法取得成功,它們可能會形成相互競爭的實證醫學干預措施,從而降低營養療法在腦部健康方面的相對提案,尤其對於那些尋求最高級別循證認知支持干預措施的臨床導向型消費者而言。隨著醫療專業人員擴大為高風險患者開立認知增強藥物,處方藥選擇範圍的擴大可能會導致膳食補充劑的建議率下降。
新冠疫情帶來的壓力,包括腦霧、認知障礙和心理健康問題,導致許多人的認知功能迅速下降,引發了消費者對腦部健康營養支持產品前所未有的需求。疫情後人們對認知功能的焦慮、對新冠長期腦霧的認知不斷提高,以及專業對最佳化腦力表現的投入增加,持續推動著腦部健康營養市場以遠超疫情前水準的速度成長。
在預測期內,胺基酸細分市場預計將佔據最大佔有率。
預計在預測期內,胺基酸類產品將佔據最大的市場佔有率。這是因為大量的臨床證據表明,某些氨基酸化合物在腦部健康方面具有顯著功效,例如L-茶氨酸可緩解焦慮和提高注意力,乙醯左旋肉鹼可激活認知功能,絲胺酸可增強記憶力,GABA可用於壓力管理,這些都為補充劑的有效性提供了可靠的證據。優質的氨基酸類腦健康補充劑憑藉消費者親身驗證的功效,贏得了消費者的廣泛支持,並且其複購率高於其他腦健康成分類別。
在預測期內,營養補充品細分市場預計將呈現最高的複合年成長率。
在預測期內,營養補充品領域預計將呈現最高的成長率。這主要歸功於消費者日常服用營養補充劑以維持大腦健康的習慣日益普及,這種習慣正從專業的生物駭客群體逐漸被更廣泛的健康意識人群所接受。此外,專業大腦健康補充劑品牌的湧現也帶來了多樣化的產品選擇,包括促智組合配方、單一氨基酸化合物和綜合認知支持配方,所有這些都擴大了該品類的消費者涵蓋範圍和購買頻率。
在預測期內,北美預計將佔據最大的市場佔有率。這是因為美國擁有全球最商業性的腦部健康補充劑市場,旗下擁有Neurova(利潔時)、Jarrow Formulas和NOW Foods等領先品牌,以及眾多在國內創造可觀收入的高階益智藥品牌;此外,美國還擁有強大的生物駭客和認知補充劑消費文化,推動了對高階腦部健康的投資購買;並且擁有先進的電子商務基礎設施。
在預測期內,亞太地區預計將呈現最高的複合年成長率。這主要是因為日本擁有全球最大的老年人口,且人均認知健康補充劑消費量最高;中國和印度不斷壯大的專業消費者對大腦健康的認知度正在迅速提高;此外,Blackmores、Swisse 等本土品牌以及亞太地區其他區域品牌大力開發本土大腦健康補充劑,這些因素共同推動了該地區認知健康領域投資的成長。
According to Stratistics MRC, the Global Brain Health Nutrition Market is accounted for $18.4 billion in 2026 and is expected to reach $48.6 billion by 2034 growing at a CAGR of 12.9% during the forecast period. Brain health nutrition refers to functional food and supplement products formulated with omega-3 fatty acids, nootropic compounds, vitamins and minerals, and amino acids in dietary supplement, functional beverage, functional food, and infant and pediatric nutrition delivery formats designed to support cognitive performance including memory, focus, and processing speed, protect against age-related cognitive decline, support infant and childhood brain development, and maintain mental clarity and emotional resilience through evidence-informed nutritional intervention strategies targeting the full lifespan from prenatal development through healthy aging.
Cognitive Performance Optimization Consumer Investment
Growing consumer investment in cognitive performance optimization from professional productivity improvement, healthy aging cognitive preservation, and pediatric developmental support motivations is creating a large and diverse brain health nutrition market spanning life stage applications from infant DHA supplementation through elderly dementia prevention. Growing awareness of lifestyle nutrition factors in long-term cognitive health outcomes combined with expanding neuroscience research publication reaching mainstream health media is generating educated consumer populations investing in evidence-supported brain health nutritional intervention across multiple age and performance objective segments.
Brain Health Claim Regulatory Restrictions
Strict regulatory limitations on brain health and cognitive benefit claims for food and supplement products under FDA and EFSA frameworks restricting permissible cognitive function, memory, and mental performance claim language to broadly defined structure-function statements constrains consumer education effectiveness for brain health nutrition brands, requiring significant investment in educational content marketing that communicates scientific evidence for ingredient mechanisms without triggering impermissible disease treatment or cognitive enhancement drug claim regulatory classification.
Senior Cognitive Health Prevention Market
Rapidly growing aging global population creating expanding senior consumer segment actively seeking nutritional strategies for cognitive health preservation and dementia risk reduction represents a high-value brain health nutrition market opportunity where healthcare provider engagement, caregiver purchasing influence, and consumer willingness to invest in cognitive protection justify premium product pricing. Documented omega-3, B-vitamin, and phosphatidylserine clinical evidence for cognitive health support in aging populations creates strong professional recommendation channel for premium brain health nutrition products.
Pharmaceutical Cognitive Drug Pipeline Competition
Growing pharmaceutical pipeline for approved cognitive enhancement and dementia prevention treatments attracting clinical trial investment that if successful could create competing evidence-based medical interventions reducing relative value proposition of nutritional brain health approaches for clinically motivated consumer segments seeking highest-evidence cognitive support intervention. Healthcare provider prescribing of pharmaceutical cognitive agents for high-risk patients may reduce supplement recommendation rates as prescription cognitive drug options expand.
COVID-19 brain fog, cognitive impairment, and mental health impacts from infection and pandemic stress generated unprecedented consumer motivation for brain health nutritional support as large populations experienced acute cognitive performance decline. Post-pandemic sustained cognitive health anxiety, long COVID brain fog awareness, and elevated mental performance optimization investment across professional demographics continue driving brain health nutrition market growth well above pre-pandemic trend rates.
The amino acids segment is expected to be the largest during the forecast period
The amino acids segment is expected to account for the largest market share during the forecast period, due to the extensive clinical evidence for specific amino acid compounds in brain health applications including L-theanine for anxiety and focus, acetyl-L-carnitine for cognitive energy, phosphatidylserine for memory, and GABA for stress management that enable credible supplement claim substantiation. Premium amino acid brain health supplement formulations command strong consumer loyalty through documented personal efficacy experience that sustains repeat purchase above alternative brain health ingredient categories.
The dietary supplements segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the dietary supplements segment is predicted to witness the highest growth rate, driven by expanding consumer adoption of daily brain health supplement protocols from professional biohacking communities mainstreaming into broader health-conscious demographics, combined with specialty brain health supplement brand proliferation creating diverse product options across nootropic stack formulations, individual amino acid compounds, and comprehensive cognitive support formulas that collectively expand category consumer reach and purchase frequency.
During the forecast period, the North America region is expected to hold the largest market share, due to the United States hosting the world's most commercially developed brain health supplement market with leading brands including Neuriva (Reckitt), Jarrow Formulas, NOW Foods, and premium nootropic brands generating substantial domestic revenue, strong biohacking and cognitive optimization consumer culture sustaining premium brain health supplement investment, and advanced supplement retail and DTC e-commerce infrastructure.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to Japan hosting the world's largest aging population with the highest cognitive health supplement consumption per capita, rapidly growing brain health awareness among China and India's expanding professional middle-class consumer segments, and strong domestic brain health supplement development from Blackmores, Swisse, and regional brands serving Asia Pacific market cognitive health investment growth.
Key players in the market
Some of the key players in Brain Health Nutrition Market include Nestle Health Science, Abbott Laboratories, Danone S.A., Reckitt Benckiser Group plc, BASF SE, DSM-Firmenich AG, Kerry Group plc, ADM Company, Pfizer Inc., Amway Corp., Herbalife Ltd., Blackmores Limited, Swisse Wellness, Neuriva (Reckitt), NOW Foods, and Jarrow Formulas Inc..
In April 2026, Neuriva (Reckitt) launched a new clinically validated brain health supplement combining phosphatidylserine and L-theanine with lion's mane mushroom extract supported by published 12-week cognitive performance randomized controlled trial with validated memory and focus outcome measures.
In March 2026, DSM-Firmenich AG introduced a new lyso-phosphatidylcholine DHA form demonstrating 2.5 times superior brain DHA incorporation versus standard ethyl ester omega-3 in a clinical bioavailability study enabling premium brain health supplement ingredient positioning.
In December 2025, Blackmores Limited expanded its brain health supplement portfolio with a comprehensive cognitive longevity formula targeting the Asian aging population market combining phosphatidylserine, bacopa, and ubiquinol with published clinical evidence for elderly cognitive health support.
In November 2025, Jarrow Formulas Inc. secured major US and European specialty health retailer distribution for its Cognizin citicoline brain health supplement line following independent clinical study publication demonstrating 18 percent attention and memory improvement in healthy adults.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.